Gliatilin solution 1000mg / 3ml, No. 3

• acute period of traumatic brain injury with a predominantly stem level of the lesion,

• chronic cerebrovascular insufficiency (discirculatory encephalopathy);

• dementia syndrome of various origins, incl. Alzheimer's disease;

• ischemic stroke (early and late recovery period);

• chorea of ??Gettington; senile pseudomelancholia.

In / m or / in (drip, slowly) at a dose of 1000 mg / day (1 amp.), For 10 days.

Doses and duration of treatment, if necessary and well tolerated, can be increased by the attending physician, depending on the clinical picture, characteristics of the course of the disease, age and tolerability of the drug. If undesirable reactions appear, a temporary dose reduction is possible.

Children. There is no experience with the use of Gliatilin in children.

1 amp.

active substance: choline alfoscerate 1000mg

excipients: water for injection - up to 3 ml

Pregnancy, lactation, hypersensitivity to choline alfoscerate.

Solution for infusion and intramuscular administration

1 amp.

active substance: choline alfoscerate 1000mg

excipients: water for injection - up to 3 ml

Clinical and pharmacological group: Nootropic drug. Centrally acting cholinomimetic

Pharmaco-therapeutic group: Nootropic agent

pharmachologic effect

Cholinomimetic. It is a precursor to acetylcholine. It has an effect mainly on cholinergic receptors in the central nervous system. Glycerophosphate, which is formed during the breakdown of choline alfoscerate, is a precursor of phospholipids (phosphatidylcholine) of the neuron membrane. Facilitates the transmission of nerve impulses in cholinergic neurons, improves the plasticity of neuronal membranes and receptor function.

Indications of the active substances of the drug Gliatilin

Acute period of traumatic brain injury with a predominantly stem level of the lesion, chronic cerebrovascular insufficiency (discirculatory encephalopathy); dementia syndrome of various origins, incl. Alzheimer's disease; ischemic stroke (early and late recovery period); chorea of ??Gettington; senile pseudomelancholia.

Method of administration and dosage

In / m or / in (drip, slowly) at a dose of 1000 mg / day (1 amp.), For 10 days.

Doses and duration of treatment, if necessary and well tolerated, can be increased by the attending physician, depending on the clinical picture, characteristics of the course of the disease, age and tolerability of the drug. If undesirable reactions appear, a temporary dose reduction is possible.

Children. There is no experience with the use of Gliatilin in children.

Contraindications for use

Pregnancy, lactation, hypersensitivity to choline alfoscerate.

Release form

Solution for infusion and intramuscular administration , 1000 mg / 3 ml. 3 ml in ampoules of neutral colorless glass, type I. 3, 5 or 6 amp. in a contour acheikova packing. 1 blister is placed in a cardboard box.

3 amp. placed in a blister strip packaging. 2 blisters are placed in a cardboard box.

Manufacturer

Italfarmako S.p.A., Viale Fulvio Testi 330, 20126, Milan, Italy.

Consumer claims on the quality of the drug are accepted by the representative office of JSC 'Italfarmako' 115432, Moscow, Andropova ave., 18, bldg. 6, office. 4-01.

Tel .: (495) 933-14-58; fax: (495) 626-56-58.

Conditions of dispensing from pharmacies

On prescription.

Storage conditions of the drug Gliatilin

In a dark place at a temperature not exceeding 25 ? C.

Keep out of the reach of children.